drugset / Trial / NCT00171964

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions

NCT00171964

Phase 4 Completed 75 enrolled Novartis Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.

Timeline

Start
2002-05
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified